Terms: = Pancreatic cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Prognosis
21 results:
1. timp1 derived from pancreatic cancer cells stimulates Schwann cells and promotes the occurrence of perineural invasion.
Tian Z; Ou G; Su M; Li R; Pan L; Lin X; Zou J; Chen S; Li Y; Huang K; Chen Y
Cancer Lett; 2022 Oct; 546():215863. PubMed ID: 35961511
[TBL] [Abstract] [Full Text] [Related]
2. timp1 Triggers Neutrophil Extracellular Trap Formation in pancreatic cancer.
Schoeps B; Eckfeld C; Prokopchuk O; Böttcher J; Häußler D; Steiger K; Demir IE; Knolle P; Soehnlein O; Jenne DE; Hermann CD; Krüger A
Cancer Res; 2021 Jul; 81(13):3568-3579. PubMed ID: 33941611
[TBL] [Abstract] [Full Text] [Related]
3. Eosinophils in the pathogenesis of pancreatic disorders.
Manohar M; Kandikattu HK; Upparahalli Venkateshaiah S; Yadavalli CS; Mishra A
Semin Immunopathol; 2021 Jun; 43(3):411-422. PubMed ID: 33783592
[TBL] [Abstract] [Full Text] [Related]
4. A novel tissue inhibitor of metalloproteinases-1/liver/cachexia score predicts prognosis of gastrointestinal cancer patients.
Prokopchuk O; Hermann CD; Schoeps B; Nitsche U; Prokopchuk OL; Knolle P; Friess H; Martignoni ME; Krüger A
J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):378-392. PubMed ID: 33590974
[TBL] [Abstract] [Full Text] [Related]
5. IL35 predicts prognosis in gastric cancer and is associated with angiogenesis by altering timp1, PAI1 and IGFBP1.
Li X; Niu N; Sun J; Mou Y; He X; Mei L
FEBS Open Bio; 2020 Dec; 10(12):2687-2701. PubMed ID: 33064893
[TBL] [Abstract] [Full Text] [Related]
6. Novel scoring system for recurrence risk classification of surgically resected G1/2 pancreatic neuroendocrine tumors - Retrospective cohort study.
Zou S; Jiang Y; Wang W; Zhan Q; Deng X; Shen B
Int J Surg; 2020 Feb; 74():86-91. PubMed ID: 31926324
[TBL] [Abstract] [Full Text] [Related]
7. Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma.
Yu S; Li Y; Liao Z; Wang Z; Wang Z; Li Y; Qian L; Zhao J; Zong H; Kang B; Zou WB; Chen K; He X; Meng Z; Chen Z; Huang S; Wang P
Gut; 2020 Mar; 69(3):540-550. PubMed ID: 31562239
[TBL] [Abstract] [Full Text] [Related]
8. Key genes associated with pancreatic cancer and their association with outcomes: A bioinformatics analysis.
Wu J; Li Z; Zeng K; Wu K; Xu D; Zhou J; Xu L
Mol Med Rep; 2019 Aug; 20(2):1343-1352. PubMed ID: 31173193
[TBL] [Abstract] [Full Text] [Related]
9. FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis.
Liu L; Zhi Q; Shen M; Gong FR; Zhou BP; Lian L; Shen B; Chen K; Duan W; Wu MY; Tao M; Li W
Oncotarget; 2016 Jul; 7(30):47145-47162. PubMed ID: 27323403
[TBL] [Abstract] [Full Text] [Related]
10. Targeting pancreatic cancer using a combination of gemcitabine with the omega-3 polyunsaturated fatty acid emulsion, Lipidem™.
Haqq J; Howells LM; Garcea G; Dennison AR
Mol Nutr Food Res; 2016 Jun; 60(6):1437-47. PubMed ID: 26603273
[TBL] [Abstract] [Full Text] [Related]
11. Identification of Novel Biomarkers for Metastatic Colorectal cancer Using Angiogenesis-Antibody Array and Intracellular Signaling Array.
Chung S; Dwabe S; Elshimali Y; Sukhija H; Aroh C; Vadgama JV
PLoS One; 2015; 10(8):e0134948. PubMed ID: 26258407
[TBL] [Abstract] [Full Text] [Related]
12. Identification of ANXA1 as a lymphatic metastasis and poor prognostic factor in pancreatic ductal adenocarcinoma.
Liu QH; Shi ML; Bai J; Zheng JN
Asian Pac J Cancer Prev; 2015; 16(7):2719-24. PubMed ID: 25854353
[TBL] [Abstract] [Full Text] [Related]
13. A single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram.
Ellison TA; Wolfgang CL; Shi C; Cameron JL; Murakami P; Mun LJ; Singhi AD; Cornish TC; Olino K; Meriden Z; Choti M; Diaz LA; Pawlik TM; Schulick RD; Hruban RH; Edil BH
Ann Surg; 2014 Feb; 259(2):204-12. PubMed ID: 23673766
[TBL] [Abstract] [Full Text] [Related]
14. Angiogenesis markers quantification in breast cancer and their correlation with clinicopathological prognostic variables.
Rykala J; Przybylowska K; Majsterek I; Pasz-Walczak G; Sygut A; Dziki A; Kruk-Jeromin J
Pathol Oncol Res; 2011 Dec; 17(4):809-17. PubMed ID: 21560015
[TBL] [Abstract] [Full Text] [Related]
15. Clinical significance of the measurements of serum matrix metalloproteinase-9 and its inhibitor (tissue inhibitor of metalloproteinase-1) in patients with pancreatic cancer: metalloproteinase-9 as an independent prognostic factor.
Mroczko B; Lukaszewicz-Zajac M; Wereszczynska-Siemiatkowska U; Groblewska M; Gryko M; Kedra B; Jurkowska G; Szmitkowski M
Pancreas; 2009 Aug; 38(6):613-8. PubMed ID: 19629003
[TBL] [Abstract] [Full Text] [Related]
16. The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters.
Giannopoulos G; Pavlakis K; Parasi A; Kavatzas N; Tiniakos D; Karakosta A; Tzanakis N; Peros G
Anticancer Res; 2008; 28(3B):1875-81. PubMed ID: 18630474
[TBL] [Abstract] [Full Text] [Related]
17. Increased expression of matrix metalloproteinases-21 and -26 and timp-4 in pancreatic adenocarcinoma.
Bister V; Skoog T; Virolainen S; Kiviluoto T; Puolakkainen P; Saarialho-Kere U
Mod Pathol; 2007 Nov; 20(11):1128-40. PubMed ID: 17873896
[TBL] [Abstract] [Full Text] [Related]
18. Hypoxia augments gelatinase activity in a variety of adenocarcinomas in vitro.
Ridgway PF; Ziprin P; Alkhamesi N; Paraskeva PA; Peck DH; Darzi AW
J Surg Res; 2005 Apr; 124(2):180-6. PubMed ID: 15820246
[TBL] [Abstract] [Full Text] [Related]
19. Enhanced mRNA expression of tissue inhibitor of metalloproteinase-1 (timp-1) in breast carcinomas is correlated with adverse prognosis.
Nakopoulou L; Giannopoulou I; Stefanaki K; Panayotopoulou E; Tsirmpa I; Alexandrou P; Mavrommatis J; Katsarou S; Davaris P
J Pathol; 2002 Jul; 197(3):307-13. PubMed ID: 12115876
[TBL] [Abstract] [Full Text] [Related]
20. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.
Yamamoto H; Itoh F; Iku S; Adachi Y; Fukushima H; Sasaki S; Mukaiya M; Hirata K; Imai K
J Clin Oncol; 2001 Feb; 19(4):1118-27. PubMed ID: 11181677
[TBL] [Abstract] [Full Text] [Related]
[Next]
